Martine Keenan

Suite 5, 3 Brodie Hall Drive, Technology Park
Bentley, WA 6102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

Journal: Science translational medicine

Published: December 13, 2023

Short-course combination treatment for experimental chronic Chagas disease.

Short-course combination treatment for experimental chronic Chagas disease.

Journal: Science translational medicine

Published: December 13, 2023

Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy.

Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy.

Journal: European journal of medicinal chemistry

Published: June 21, 2020

A new era for chagas disease drug discovery?

A new era for chagas disease drug discovery?

Journal: Progress in medicinal chemistry

Published: March 03, 2015

Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.

Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.

Journal: Journal of medicinal chemistry

Published: December 06, 2013

Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi.

Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi.

Journal: Future medicinal chemistry

Published: October 23, 2013

Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.

Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.

Journal: The Journal of biological chemistry

Published: September 20, 2013

Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.

Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.

Journal: Prostate cancer and prostatic diseases

Published: March 13, 2013

Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi.

Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi.

Journal: Bioorganic & medicinal chemistry

Published: November 15, 2012

Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.

Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.

Journal: Journal of medicinal chemistry

Published: April 28, 2012

Boron-based drugs as antiprotozoals.

Boron-based drugs as antiprotozoals.

Journal: Current opinion in infectious diseases

Published: October 18, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026